Invention Grant
- Patent Title: Histamine H3 receptor agents, preparation and therapeutic uses
- Patent Title (中): 组胺H3受体剂，制剂及治疗用途
-
Application No.: US11569803Application Date: 2005-05-24
-
Publication No.: US07696234B2Publication Date: 2010-04-13
- Inventor: Lisa Selsam Beavers , Robert Alan Gadski , Cynthia Darshini Jesudason , Richard Todd Pickard , Freddie Craig Stevens
- Applicant: Lisa Selsam Beavers , Robert Alan Gadski , Cynthia Darshini Jesudason , Richard Todd Pickard , Freddie Craig Stevens
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Dan L. Wood
- International Application: PCT/US2005/018249 WO 20050524
- International Announcement: WO2005/121080 WO 20051222
- Main IPC: A61K31/4439
- IPC: A61K31/4439 ; A61K31/4025 ; C07D401/14 ; C07D207/04 ; C07D205/04
Abstract:
The present invention discloses novel compounds of Formula I or pharmaceutically acceptable salts thereof which have histamine-H3 receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using these compositions to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases.
Public/Granted literature
- US20090118254A1 HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES Public/Granted day:2009-05-07
Information query
IPC分类:
